Applications open for T2B's IR Roundtable
|
Hi! T2B's Investor Relations Roundtable is adding three new members for Year 2. If you work at the intersection of IR and corporate comms — whether that's your primary focus or part of a broader role — we invite you to consider applying. About the roundtableChaired by Deborah Elson, Senior Director, Corporate Communications and Investor Relations at Tonix Pharmaceuticals, the roundtable is a small working group focused on advancing IR practice across the biopharma industry. Returning members include David Connolly (Rhythm Pharmaceuticals) and Elizabeth Higgins (formerly Astria Therapeutics). Roundtable details here. “With investor relations and corporate communications intertwined more than ever in biotech to shape positioning and enhance credibility, I am pleased to collaborate with others to advance learning and connectivity that strengthen our IR savvy.” - Deborah Elson What the group works onIn Year 1, the roundtable tackled real challenges facing IR and communications professionals, from ESG strategy and ratings agencies to how IR priorities shift across market caps. Year 2 builds on those conversations, with a continued focus on:
What roundtable members doThis is not an advisory role. Roundtable members are hands-on leaders who:
EligibilityApplicants must hold an active T2B Pro membership and have experience in biopharma IR on the agency, in-house, and/or consulting side. Apply by Tuesday, April 21st Thanks! Lynnea |
T2B Monthly
Hi! A quick reminder that tomorrow we’ll hold our Q2 Patient Advocacy & Engagement Roundtable event. This conversation will look at how biopharma communications are actually experienced by patient organizations... where messaging resonates, where it falls short, and what helps build stronger, more trusted relationships over time. Our speakers will share perspectives on what patient advocacy groups need from biopharma communicators, including how trust is built in practice, what makes...
Hi, Our Q1 masterclass explored what it means for biopharma communicators to show up fully as strategic partners, focusing on how we understand the business, structure our work, and make our impact more visible. Andrea Johnston led the session, bringing a builder’s perspective shaped by 30+ years across corporate, agency, and entrepreneurship (including one of the OG firms in our industry, Pure Communications). Here are 10 takeaways that stood out: Understand the economics of your clients' or...
Hi! Patient organizations are the closest link to the communities biopharma aims to serve. They see firsthand how messaging lands, including where it resonates, where it misses, and where it creates unintended friction. Our upcoming Patient Advocacy & Engagement Roundtable event brings together leaders across patient advocacy, healthcare communications, and patient-centered innovation to share how biopharma communications are experienced on the receiving end. What Patient Advocacy...